APA

Nagy A., Plonowski A. & Schally A. V. (20000302). Stability of cytotoxic luteinizing hormone-releasing hormone conjugate (AN-152) containing doxorubicin 14-O-hemiglutarate in mouse and human serum in vitro: implications for the design of preclinical studies. : Proceedings of the National Academy of Sciences of the United States of America.

Chicago

Nagy A, Plonowski A and Schally A V. 20000302. Stability of cytotoxic luteinizing hormone-releasing hormone conjugate (AN-152) containing doxorubicin 14-O-hemiglutarate in mouse and human serum in vitro: implications for the design of preclinical studies. : Proceedings of the National Academy of Sciences of the United States of America.

Harvard

Nagy A., Plonowski A. and Schally A. V. (20000302). Stability of cytotoxic luteinizing hormone-releasing hormone conjugate (AN-152) containing doxorubicin 14-O-hemiglutarate in mouse and human serum in vitro: implications for the design of preclinical studies. : Proceedings of the National Academy of Sciences of the United States of America.

MLA

Nagy A, Plonowski A and Schally A V. Stability of cytotoxic luteinizing hormone-releasing hormone conjugate (AN-152) containing doxorubicin 14-O-hemiglutarate in mouse and human serum in vitro: implications for the design of preclinical studies. : Proceedings of the National Academy of Sciences of the United States of America. 20000302.